Open the mobile version, with barcode scanning
Class II Ongoing

Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc.

Why: CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.

Company
Hikma Pharmaceuticals USA INC.
Columbus, OH, United States
Reported
Nov 11, 2026
Recall started
Oct 20, 2026
Where sold
US Nationwide
Amount
29,085 bottles
Full product description
Ciprofloxacin Tablets, USP, 500 mg, 100-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9928-01
Lots / codes affected
Lot# CB496A; Exp. 12/31/2026 Lot# CB497A; Exp. 12/31/2026 Lot# CB498A; Exp. 12/31/2026

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.